This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaul, P. Search for Related Content PubMed PubMed Citation Articles by Kaul, P.

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb¹

Padma Kaul, PhD^*, Yuling Fu, MD^*, Wei-Ching Chang, PhD^*, Robert A. Harrington, MD, Galen S. Wagner, MD, Shaun G. Goodman, MD, Christopher B. Granger, MD, David J. Moliterno, MD, Frans Van de Werf, MD^||, Robert M. Califf, MD, Eric J. Topol, MD, Paul W. Armstrong, MD^* for the PARAGON-A and GUSTO-IIb Investigators

^* University of Alberta, Edmonton, Alberta, Canada
Duke Clinical Research Institute, Durham, North Carolina, USA
St. Michael’s Hospital, Toronto, Ontario, Canada
Cleveland Clinic Foundation, Cleveland, Ohio, USA
^|| University Hospital Gasthuisberg, Leuven, Belgium

View larger version (17K): [in a new window]   Figure 1 Survival curves corresponding to the categories of no ST segment depression (dep), 1-mm ST segment depression and 2-mm ST segment depression in the PARAGON-A study (A) and GUSTO-IIb (B) studies. Log-rank tests were used to compare the survival curves. All curves were statistically significantly different at p < 0.05.

View larger version (17K): [in a new window]   Figure 2 Relative contribution of baseline risk factors in predicting one-year mortality (PARAGON-A data). CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; CVD = cerebrovascular disease; MI = myocardial infarction; PTCA = percutaneous transluminal coronary angioplasty; PVD = peripheral vascular disease.